127 related articles for article (PubMed ID: 37052942)
1. T-ALL in CNS-3 status needs improvement.
Ribera JM
Blood; 2023 Apr; 141(15):1779-1780. PubMed ID: 37052942
[No Abstract] [Full Text] [Related]
2. [Clinical Features and Prognosis of Acute T-cell Lymphoblastic Leukemia in Children--Multi-Center Data Analysis in Fujian].
Wu CP; Zheng YZ; Li J; Wen H; Weng KZ; Zhuang SQ; Wu XG; Hua XL; Zheng H; Chen ZS; LE SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):6-13. PubMed ID: 38387892
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognosis of children with recurrent T-cell acute lymphoblastic leukemia: a long-term follow-up report in China.
Liu X; Zou Y; Zhang L; Zhang Y; Chen Y; Chen X; Guo Y; Yang W; Zhu X
Leuk Lymphoma; 2022 Dec; 63(14):3462-3474. PubMed ID: 36107030
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease surveillance at day 90 predicts long-term survival in pediatric patients with T-cell acute lymphoblastic leukemia.
Liu X; Zou Y; Chen X; Wang S; Guo Y; Yang W; Zhang L; Chen Y; Zhang Y; Zhu X
Leuk Lymphoma; 2020 Dec; 61(14):3460-3467. PubMed ID: 32779947
[TBL] [Abstract][Full Text] [Related]
5. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study.
Pullen J; Shuster JJ; Link M; Borowitz M; Amylon M; Carroll AJ; Land V; Look AT; McIntyre B; Camitta B
Leukemia; 1999 Nov; 13(11):1696-707. PubMed ID: 10557041
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.
Fielding AK; Banerjee L; Marks DI
Curr Hematol Malig Rep; 2012 Jun; 7(2):160-9. PubMed ID: 22476945
[TBL] [Abstract][Full Text] [Related]
7. Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL.
O'Connor D; Joy M; Enshaei A; Kirkwood A; Kearns PR; Samarasinghe S; Moppett J; Moorman AV; Vora A
Blood Adv; 2023 Dec; 7(23):7231-7234. PubMed ID: 37824845
[No Abstract] [Full Text] [Related]
8. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
[TBL] [Abstract][Full Text] [Related]
9. Refining genetic stratification in T-ALL.
O'Connor D
Blood; 2018 Jan; 131(3):271-272. PubMed ID: 29348308
[No Abstract] [Full Text] [Related]
10. T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development.
Thomas X
Expert Opin Investig Drugs; 2023 Jan; 32(1):37-52. PubMed ID: 36541671
[TBL] [Abstract][Full Text] [Related]
11. CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS.
Oruganti SR; Torres DJ; Krebsbach S; Asperti-Boursin F; Winters J; Matlawska-Wasowska K; Winter SS; Halsey C; Cannon JL
Leukemia; 2017 Jan; 31(1):255-258. PubMed ID: 27698445
[No Abstract] [Full Text] [Related]
12. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
[TBL] [Abstract][Full Text] [Related]
13. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma from Multicenter].
Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
[TBL] [Abstract][Full Text] [Related]
15. SET-CAN fusion gene as poor prognosis predictor in adult T-cell acute lymphoblastic leukemia.
Yang Q; Qian H; Jin Z; Yu Z; Yu K; Zhang S; Jiang S
Leuk Lymphoma; 2020 Jan; 61(1):217-220. PubMed ID: 31502502
[No Abstract] [Full Text] [Related]
16. Abnormal Lymphoid Cells in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Resembling Burkitt Lymphoma Morphology.
Yu Y; Chen X
Turk J Haematol; 2023 Aug; 40(3):230-231. PubMed ID: 37338279
[No Abstract] [Full Text] [Related]
17. Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies.
Stark B; Avrahami G; Nirel R; Abramov A; Attias D; Ballin A; Bielorai B; Burstein Y; Gavriel H; Elhasid R; Kapelushnik J; Sthoeger D; Toren A; Wientraub M; Yaniv I; Izraeli S
Br J Haematol; 2009 Oct; 147(1):113-24. PubMed ID: 19694717
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal mass in T-cell acute lymphoblastic leukaemia.
Teepapan P; Kaewphichai P; Smithtithiti S; Morasert T
Postgrad Med J; 2021 May; 97(1147):337. PubMed ID: 32709634
[No Abstract] [Full Text] [Related]
19. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib-therapy induced sustained remission in a child with refractory TCF7-SPI1 T-cell acute lymphoblastic leukemia.
He Y; Zhang J; Zhang Y; Hu Z; Wang P; Gan W; Xie S; Qian M; Pui CH; Jiang H; Zhu X; Zhang H; Zhang W
Pediatr Blood Cancer; 2022 Aug; 69(8):e29724. PubMed ID: 35441457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]